Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Hormonal Contraception and HIV: Technical Statement.

Geneva: World Health Organization; 2012 Feb 16.

2.

Hormonal contraception and the risk of HIV acquisition among women in South Africa.

Morrison CS, Skoler-Karpoff S, Kwok C, Chen PL, van de Wijgert J, Gehret-Plagianos M, Patel S, Ahmed K, Ramjee G, Friedland B, Lahteenmaki P.

AIDS. 2012 Feb 20;26(4):497-504. doi: 10.1097/QAD.0b013e32834fa13d.

PMID:
22156973
3.

The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections.

Wand H, Ramjee G.

AIDS. 2012 Jan 28;26(3):375-80. doi: 10.1097/QAD.0b013e32834f990f.

PMID:
22156970
4.

Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study.

Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, de Bruyn G, Nakku-Joloba E, Ngure K, Kiarie J, Coombs RW, Baeten JM; Partners in Prevention HSV/HIV Transmission Study Team.

Lancet Infect Dis. 2012 Jan;12(1):19-26. doi: 10.1016/S1473-3099(11)70247-X. Epub 2011 Oct 3. Erratum in: Lancet Infect Dis. 2012 Feb;12(2):98.

5.

Low-dose combined oral contraceptive and cervicovaginal shedding of human immunodeficiency virus.

Roccio M, Gardella B, Maserati R, Zara F, Iacobone D, Spinillo A.

Contraception. 2011 Jun;83(6):564-70. doi: 10.1016/j.contraception.2010.10.008. Epub 2010 Dec 3.

PMID:
21570555
6.

Correlates of HIV-1 genital shedding in Tanzanian women.

Tanton C, Weiss HA, Le Goff J, Changalucha J, Rusizoka M, Baisley K, Everett D, Ross DA, Belec L, Hayes RJ, Watson-Jones D.

PLoS One. 2011 Mar 1;6(3):e17480. doi: 10.1371/journal.pone.0017480.

7.

Effect of hormonal contraceptive use before HIV seroconversion on viral load setpoint among women in Rakai, Uganda.

Polis CB, Gray RH, Bwanika JB, Kigozi G, Kiwanuka N, Nalugoda F, Kagaayi J, Lutalo T, Serwadda D, Wawer MJ.

J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):125-30. doi: 10.1097/QAI.0b013e3181fbcc11.

8.

The levonorgestrel-releasing intrauterine system in human immunodeficiency virus-infected women: a 5-year follow-up study.

Heikinheimo O, Lehtovirta P, Aho I, Ristola M, Paavonen J.

Am J Obstet Gynecol. 2011 Feb;204(2):126.e1-4. doi: 10.1016/j.ajog.2010.09.002. Epub 2010 Oct 29.

PMID:
21035781
9.

Antiretroviral adherence and development of drug resistance are the strongest predictors of genital HIV-1 shedding among women initiating treatment.

Graham SM, Masese L, Gitau R, Jalalian-Lechak Z, Richardson BA, Peshu N, Mandaliya K, Kiarie JN, Jaoko W, Ndinya-Achola J, Overbaugh J, McClelland RS.

J Infect Dis. 2010 Nov 15;202(10):1538-42. doi: 10.1086/656790. Epub 2010 Oct 5.

10.

Baseline factors associated with incident HIV and STI in four microbicide trials.

Feldblum PJ, Lie CC, Weaver MA, Van Damme L, Halpern V, Adeiga A, Bakare R, Schwartz J, Becker M, Solomon S.

Sex Transm Dis. 2010 Oct;37(10):594-601.

PMID:
20879087
11.

Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling.

Morrison CS, Chen PL, Kwok C, Richardson BA, Chipato T, Mugerwa R, Byamugisha J, Padian N, Celentano DD, Salata RA.

AIDS. 2010 Jul 17;24(11):1778-81. doi: 10.1097/QAD.0b013e32833a2537.

12.

Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda.

Polis CB, Wawer MJ, Kiwanuka N, Laeyendecker O, Kagaayi J, Lutalo T, Nalugoda F, Kigozi G, Serwadda D, Gray RH.

AIDS. 2010 Jul 31;24(12):1937-44. doi: 10.1097/QAD.0b013e32833b3282.

13.

Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection.

Morrison CS, Demers K, Kwok C, Bulime S, Rinaldi A, Munjoma M, Dunbar M, Chipato T, Byamugisha J, Van Der Pol B, Arts E, Salata RA.

AIDS. 2010 Feb 20;24(4):573-82. doi: 10.1097/QAD.0b013e32833433df.

14.

Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-Plus Initiative.

Stringer EM, Giganti M, Carter RJ, El-Sadr W, Abrams EJ, Stringer JS; MTCT-Plus Initiative.

AIDS. 2009 Nov;23 Suppl 1:S69-77. doi: 10.1097/01.aids.0000363779.65827.e0.

15.

Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women.

Reid SE, Dai JY, Wang J, Sichalwe BN, Akpomiemie G, Cowan FM, Delany-Moretlwe S, Baeten JM, Hughes JP, Wald A, Celum C.

J Acquir Immune Defic Syndr. 2010 Apr;53(5):606-13. doi: 10.1097/QAI.0b013e3181bc4869.

16.

HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial.

Stringer EM, Levy J, Sinkala M, Chi BH, Matongo I, Chintu N, Stringer JS.

AIDS. 2009 Jul 17;23(11):1377-82. doi: 10.1097/QAD.0b013e32832cbca8.

17.

Risk factors for HIV incidence in women participating in an HSV suppressive treatment trial in Tanzania.

Watson-Jones D, Baisley K, Weiss HA, Tanton C, Changalucha J, Everett D, Chirwa T, Ross D, Clayton T, Hayes R.

AIDS. 2009 Jan 28;23(3):415-22. doi: 10.1097/QAD.0b013e32831ef523.

18.

HIV-1 incidence among women of reproductive age in Malawi.

Kumwenda NI, Kumwenda J, Kafulafula G, Makanani B, Taulo F, Nkhoma C, Li Q, Taha TE.

Int J STD AIDS. 2008 May;19(5):339-41. doi: 10.1258/ijsa.2007.007165.

PMID:
18482966
19.

Natural history and risk factors associated with early and established HIV type 1 infection among reproductive-age women in Malawi.

Kumwenda JJ, Makanani B, Taulo F, Nkhoma C, Kafulafula G, Li Q, Kumwenda N, Taha TE.

Clin Infect Dis. 2008 Jun 15;46(12):1913-20. doi: 10.1086/588478.

PMID:
18462100
20.

Pregnancy, hormonal contraceptive use, and HIV-related death in Rwanda.

Allen S, Stephenson R, Weiss H, Karita E, Priddy F, Fuller L, Declercq A.

J Womens Health (Larchmt). 2007 Sep;16(7):1017-27.

PMID:
17903079

Supplemental Content

Support Center